Global Newborn Screening Market Overview:
Global Newborn Screening Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2024-2035, Considering the Base Year As 2025.
Global Newborn Screening Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2035, with base year as 2025. This research study of Newborn Screening involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Newborn Screening Market:
The Newborn Screening Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Newborn Screening Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Newborn Screening Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Newborn Screening market has been segmented into:
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assays
DNA Assays
and Other Technologies
By Application, Newborn Screening market has been segmented into:
Dried Blood Spot
Hearing Screening
Critical Congenital Heart Defect (CCHD
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Newborn Screening market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Newborn Screening market.
Top Key Players Covered in Newborn Screening market are:
Natus Medical Incorporated
Trivitron Healthcare
Medtronic Inc.
Bio-Rad Laboratories Inc.
PerkinElmer
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Newborn Screening Market Type
4.1 Newborn Screening Market Snapshot and Growth Engine
4.2 Newborn Screening Market Overview
4.3 Tandem Mass Spectrometry
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.3.3 Tandem Mass Spectrometry: Geographic Segmentation Analysis
4.4 Pulse Oximetry
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.4.3 Pulse Oximetry: Geographic Segmentation Analysis
4.5 Enzyme Based Assays
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.5.3 Enzyme Based Assays: Geographic Segmentation Analysis
4.6 DNA Assays
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.6.3 DNA Assays: Geographic Segmentation Analysis
4.7 and Other Technologies
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.7.3 and Other Technologies: Geographic Segmentation Analysis
Chapter 5: Newborn Screening Market Application
5.1 Newborn Screening Market Snapshot and Growth Engine
5.2 Newborn Screening Market Overview
5.3 Dried Blood Spot
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.3.3 Dried Blood Spot: Geographic Segmentation Analysis
5.4 Hearing Screening
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.4.3 Hearing Screening: Geographic Segmentation Analysis
5.5 Critical Congenital Heart Defect (CCHD
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.5.3 Critical Congenital Heart Defect (CCHD: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Newborn Screening Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 NATUS MEDICAL INCORPORATED
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 TRIVITRON HEALTHCARE
6.4 MEDTRONIC INC.
6.5 BIO-RAD LABORATORIES INC.
6.6 PERKINELMER
Chapter 7: Global Newborn Screening Market By Region
7.1 Overview
7.2. North America Newborn Screening Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Tandem Mass Spectrometry
7.2.2.2 Pulse Oximetry
7.2.2.3 Enzyme Based Assays
7.2.2.4 DNA Assays
7.2.2.5 and Other Technologies
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Dried Blood Spot
7.2.3.2 Hearing Screening
7.2.3.3 Critical Congenital Heart Defect (CCHD
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Newborn Screening Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Tandem Mass Spectrometry
7.3.2.2 Pulse Oximetry
7.3.2.3 Enzyme Based Assays
7.3.2.4 DNA Assays
7.3.2.5 and Other Technologies
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Dried Blood Spot
7.3.3.2 Hearing Screening
7.3.3.3 Critical Congenital Heart Defect (CCHD
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Newborn Screening Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Tandem Mass Spectrometry
7.4.2.2 Pulse Oximetry
7.4.2.3 Enzyme Based Assays
7.4.2.4 DNA Assays
7.4.2.5 and Other Technologies
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Dried Blood Spot
7.4.3.2 Hearing Screening
7.4.3.3 Critical Congenital Heart Defect (CCHD
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Newborn Screening Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Tandem Mass Spectrometry
7.5.2.2 Pulse Oximetry
7.5.2.3 Enzyme Based Assays
7.5.2.4 DNA Assays
7.5.2.5 and Other Technologies
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Dried Blood Spot
7.5.3.2 Hearing Screening
7.5.3.3 Critical Congenital Heart Defect (CCHD
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Newborn Screening Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Tandem Mass Spectrometry
7.6.2.2 Pulse Oximetry
7.6.2.3 Enzyme Based Assays
7.6.2.4 DNA Assays
7.6.2.5 and Other Technologies
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Dried Blood Spot
7.6.3.2 Hearing Screening
7.6.3.3 Critical Congenital Heart Defect (CCHD
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Newborn Screening Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Tandem Mass Spectrometry
7.7.2.2 Pulse Oximetry
7.7.2.3 Enzyme Based Assays
7.7.2.4 DNA Assays
7.7.2.5 and Other Technologies
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Dried Blood Spot
7.7.3.2 Hearing Screening
7.7.3.3 Critical Congenital Heart Defect (CCHD
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Newborn Screening Scope:
|
Report Data
|
Newborn Screening Market
|
|
Newborn Screening Market Size in 2025
|
USD XX million
|
|
Newborn Screening CAGR 2025 - 2032
|
XX%
|
|
Newborn Screening Base Year
|
2024
|
|
Newborn Screening Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Natus Medical Incorporated, Trivitron Healthcare, Medtronic Inc., Bio-Rad Laboratories Inc., PerkinElmer.
|
|
Key Segments
|
By Type
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assays
DNA Assays
and Other Technologies
By Applications
Dried Blood Spot
Hearing Screening
Critical Congenital Heart Defect (CCHD
|
